BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5577160)

  • 1. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
    Beall G; Doniach D; Roitt I; el Kabir D
    J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and characterization of long-acting thyroid stimulator inhibiting factor from human thyroid tissues.
    Sato S; Noguchi S; Noguchi A
    Biochim Biophys Acta; 1972 Jul; 273(2):299-307. PubMed ID: 4673110
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 9. The subcellular localization of the long-acting thyroid stimulator inhibitor in bovine thyroid gland.
    Nitiyanant W; Dunlap D
    Endocrinology; 1978 Jul; 103(1):35-45. PubMed ID: 744082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
    Mehdi SQ; Badger J; Kriss JP
    Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Nov; 33(5):813-21. PubMed ID: 5166460
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the immunological properties of LATS.
    Ochi Y; DeGroot LJ
    Endocrinology; 1968 Oct; 83(4):845-54. PubMed ID: 4176638
    [No Abstract]   [Full Text] [Related]  

  • 20. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.